PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers
Status:
Completed
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the efficacy of a proton pump inhibitor (lansoprazole)
and a histamine-2 receptor antagonist (famotidine) in preventing recurrent ulcer bleeding in
patients with a history of H. pylori-negative idiopathic peptic ulcers.